Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 21:35 | 10/1/26 | NTRA | Health | Health | Medical Laboratories | Chapman Steven Leonard | TX | DO | CEO,P | 4 | S.m | -3,371 | 285.24 | 0 | -12 | 103 | D | |||||||||||||||
10/2/26 21:35 | 10/1/26 | NTRA | Health | Health | Medical Laboratories | Moshkevich Solomon | TX | O | P,CLINIC | 4 | S.m | -8,635 | 322.40 | 0 | -27 | 132 | D | |||||||||||||||
9/25/26 21:35 | 9/23/26 | NTRA | Health | Health | Medical Laboratories | Sheena Jonathan | TX | DH | CO-FOUND | 7 | S.m | -15,629 | 351.59 | 0 | -44 | 282 | I | |||||||||||||||
9/16/26 21:35 | 9/14/26 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | 5 | S.m | -52,481 | 335.45 | 0 | -156 | 2,280 | M | |||||||||||||||
8/28/26 21:35 | 8/10/26 | NTRA | Health | Health | Medical Laboratories | Fesko John | TX | O | P,CHIEF | 3 | S.m | -2,615 | 306.71 | 0 | -9 | 197 | D | |||||||||||||||
8/5/26 21:35 | 8/3/26 | NTRA | Health | Health | Medical Laboratories | Brophy Michael Burkes | TX | O | CFO | 2 | S.m | -1,499 | 255.79 | 0 | -6 | 52 | D | |||||||||||||||
8/5/26 21:35 | 8/3/26 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Daniel | TX | O | SEC.,GC | 2 | S.m | -575 | 258.72 | 0 | -2 | 170 | D | |||||||||||||||
7/17/26 21:05 | 7/15/26 | NTRA | Health | Health | Medical Laboratories | Chapman Rowan E | TX | D | 1 | S | -37 | 274.82 | 0 | 0 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |